General Atlantic’s Alumis Inc ALMS Stock Holding History

General Atlantic’s Portfolio ALMS Stock Details ALMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,297,530	Closed	-$5.18M	–	17
2025 Q3	$5.18M	Hold	1,297,530	–	–	0.16%	15
2025 Q2	$3.89M	Buy	+1,297,530	New	+$6.13M	0.11%	14

Other funds holding ALMS

AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

General Atlantic's ALMS Position: Q4 2025 in Review

General Atlantic sold out of Alumis Inc (ALMS) in Q4 2025, closing a stake of 1,297,530 shares — an estimated $5.18M sold.

General Atlantic first reported a position in ALMS in Q2 2025 and held it in 2 quarters. The position peaked at $5.18M in Q3 2025. 134 funds tracked by Wall St. Rank hold ALMS as of Q4 2025.

General Atlantic reported no remaining Alumis Inc position as of Q4 2025 after selling out during the quarter.
General Atlantic sold 1,297,530 Alumis Inc shares in Q4 2025, an estimated $5.18M.
General Atlantic first reported a position in Alumis Inc in Q2 2025 and held it in 2 quarters.
General Atlantic's Alumis Inc position peaked at $5.18M in Q3 2025.
134 funds tracked by Wall St. Rank held Alumis Inc as of Q4 2025.

Based on General Atlantic's 13F filing for Q4 2025, filed 17 Feb 2026.